OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ubiquitin-conjugating enzyme 2C (UBE2C) is a poor prognostic biomarker in invasive breast cancer
Yousif A. Kariri, Michael S. Toss, Mansour Alsaleem, et al.
Breast Cancer Research and Treatment (2022) Vol. 192, Iss. 3, pp. 529-539
Open Access | Times Cited: 23

Showing 23 citing articles:

The ubiquitin–proteasome system in breast cancer
Dianwen Han, Lijuan Wang, Shan Jiang, et al.
Trends in Molecular Medicine (2023) Vol. 29, Iss. 8, pp. 599-621
Closed Access | Times Cited: 46

The UBE2C/CDH1/DEPTOR axis is an oncogene and tumor suppressor cascade in lung cancer cells
Shizhen Zhang, Xia-Hong You, Yawen Zheng, et al.
Journal of Clinical Investigation (2022) Vol. 133, Iss. 4
Open Access | Times Cited: 33

UBE2C Mediates Follicular Thyroid Carcinoma Invasion and Metastasis via K29-Specific Vimentin Ubiquitination
Lei Xu, Bao Dai, Lingyun Zhang, et al.
Cancer Letters (2025), pp. 217624-217624
Closed Access

Role of UBE2C in Brain Cancer Invasion and Dissemination
Stefani Domentean, Eunice Paisana, Rita Cascão, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15792-15792
Open Access | Times Cited: 9

Enhancing risk stratification models in localized prostate cancer by novel validated tissue biomarkers
Csilla Oláh, Fabian Mairinger, Michael Wessolly, et al.
Prostate Cancer and Prostatic Diseases (2024)
Open Access | Times Cited: 2

Diverse roles of UBE2T in cancer (Review)
Nengqian Ma, Zhangzhan Li, Jingting Yan, et al.
Oncology Reports (2023) Vol. 49, Iss. 4
Open Access | Times Cited: 6

Modulation of the ubiquitin‐proteasome system by phytochemicals: Therapeutic implications in malignancies with an emphasis on brain tumors
Mehdi Sanati, Amir R. Afshari, Seyed Sajad Ahmadi, et al.
BioFactors (2023) Vol. 49, Iss. 4, pp. 782-819
Closed Access | Times Cited: 4

Ubiquitin-conjugating enzyme E2C (UBE2C) is a prognostic indicator for cholangiocarcinoma
Khaa Hoo Ong, Hong-Yue Lai, Ding‐Ping Sun, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 4

UBE2C promotes myoblast differentiation and skeletal muscle regeneration through the Akt signaling pathway
Renqiang Yuan, Xiaorong Luo, Ziyun Liang, et al.
Acta Biochimica et Biophysica Sinica (2024) Vol. 56, Iss. 7, pp. 1065-1071
Open Access | Times Cited: 1

Spatial transcriptomic analysis of amelanotic acral melanoma versus pigmented acral melanoma reveals distinct molecular determinants
Myoung Eun Choi, Eun‐Ji Choi, Jeong Hyeon Lee, et al.
British Journal of Dermatology (2024) Vol. 191, Iss. 4, pp. 580-591
Closed Access | Times Cited: 1

UBE2C regulates the KEAP1/NRF2 signaling pathway to promote the growth of gastric cancer by inhibiting autophagy
Yunhe Jiang, Bin Liu, Lifu Fu, et al.
International Journal of Biological Macromolecules (2024) Vol. 276, pp. 134011-134011
Closed Access | Times Cited: 1

System analysis identifies UBE2C as a novel oncogene target for adrenocortical carcinoma
Renlun Huang, Lang Guo, Chiwei Chen, et al.
PLoS ONE (2023) Vol. 18, Iss. 8, pp. e0289418-e0289418
Open Access | Times Cited: 3

CDK4/6 inhibitors downregulate the ubiquitin-conjugating enzymes UBE2C/S/T involved in the ubiquitin–proteasome pathway in ER + breast cancer
Chih-Yi Lin, Chung-Jen Yu, Chun‐Yu Liu, et al.
Clinical & Translational Oncology (2022) Vol. 24, Iss. 11, pp. 2120-2135
Closed Access | Times Cited: 5

Validation of a Disease-Free Survival Prediction Model Using UBE2C and Clinical Indicators in Breast Cancer Patients
Jun Shen, Huanhuan Yan, Congying Yang, et al.
Breast Cancer Targets and Therapy (2023) Vol. Volume 15, pp. 295-310
Open Access | Times Cited: 2

UBE2C promotes malignancy of cutaneous squamous cell carcinoma
Ruiting Luo, Ruimin Bai, Jiaqi Guo, et al.
Skin Research and Technology (2023) Vol. 29, Iss. 11
Open Access | Times Cited: 2

Development and validation of a prognostic model and gene co-expression networks for breast carcinoma based on scRNA-seq and bulk-seq data
Zhaohui Ruan, Dongmei Chi, Qianyu Wang, et al.
Annals of Translational Medicine (2022) Vol. 10, Iss. 24, pp. 1333-1333
Open Access | Times Cited: 3

Exploring Prognostic Gene Factors in Breast Cancer via Machine Learning
Qinglan Ma, Lei Chen, Kai‐Yan Feng, et al.
Biochemical Genetics (2024) Vol. 62, Iss. 6, pp. 5022-5050
Closed Access

Molecular Alterations Associated with Histologically Overt Stromal Response in Patients with Prostate Cancer
Mutlay Sayan, Yetkin Tuaç, Mahmut Akgul, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8913-8913
Open Access

SLIT3 deficiency promotes non-small cell lung cancer progression by modulating UBE2C/WNT signaling
Zidan Qiu, Ying Zhan, Zhiyong Chen, et al.
Open Life Sciences (2024) Vol. 19, Iss. 1
Open Access

Cell division cycle 6 (CDC6) is an independent prognostic biomarker in breast cancer
Yousif A. Kariri, Mansour Alsaleem, Abdulbaqi Al-Kawaz, et al.
Pathology (2024) Vol. 57, Iss. 3, pp. 297-304
Closed Access

Metal-organic frameworks: Biosensor applications for diagnosis of cancers
Mojtaba Hosseine, Seyed Morteza Naghib, Navid Rabiee
Microchemical Journal (2024), pp. 112341-112341
Closed Access

Page 1

Scroll to top